Target intelligence / Profile preview

Histone H2B type 1-L (H2BC13)

Target
H2BC13
Molecular classification
Histone, Chromatin structural protein
01

Overview

Histone H2B type 1-L (H2BC13) is a basic nuclear protein and a core component of the nucleosome, the fundamental unit of chromatin structure in eukaryotic cells[1][2][4][7]. Two molecules each of the four core histones—H2A, H2B (including H2BC13), H3, and H4—form an octamer around which approximately 146 base pairs of DNA are wrapped, enabling compaction and organization of the genome[1][2][4][6][7]. Histone H2B types, including H2BC13, are centrally involved in essential processes such as transcriptional regulation, DNA replication, and DNA repair[1][2][7]. They undergo extensive post-translational modifications (e.g., acetylation, ubiquitination, methylation, phosphorylation) that alter chromatin accessibility and influence gene expression and DNA processing[2][3]. H2BC13, like other replication-dependent histones, is encoded by an intronless gene and produced primarily during the S-phase of the cell cycle. It has a key structural role in nucleosome formation, contributing to chromosomal stability and epigenetic regulation, but is not considered a classical therapeutic target such as a receptor or enzyme[2][4][6]. Disruption of H2B genes or their modifications has been linked to cancer, including hematologic malignancies[1]. No approved drugs are known to selectively target H2BC13 directly, but global histone modifications are targets for certain epigenetic therapies.

Other names
H2B clustered histone 13H2BFCHIST1H2BLH2B/cdJ97D16.4histone H2B type 1-LH2B histone family member Chistone H2B.chistone cluster 1 H2B family member lhistone cluster 1 H2bl
02

Biological functions

Chromatin packagingDNA replicationDNA repairRegulation of transcriptionChromosomal stabilityEpigenetic regulation
03

Disease associations

Cancer (notably hematologic cancer)Other
04

Safety considerations

Disruption may interfere with fundamental chromatin structure/function; affects transcription, replication, and genome stability

Beyond the preview

Go deeper on Histone H2B type 1-L (H2BC13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H2B type 1-L (H2BC13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call